Journal Article Epublish 1 citation
PubMed: 38793666 DOI: 10.3390/v16050785
Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis.
Viruses 16(5)
Authors: Taylor E Martinez, Karthick Mayilsamy, Shyam S Mohapatra, Subhra Mohapatra
Affiliations
- Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
- James A Haley VA Hospital, Tampa, FL 33612, USA.
- Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Abstract
SARS-CoV-2 primarily infects the lungs via the ACE2 receptor but also other organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to the brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors ACE2 and DPP4 in the SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, and pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB, resulting in the direct infection of the brain side of the BBB model with a minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways, including the direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is an event that does not require the presence of host receptors.
MeSH
Infections, Virology, Blood-Brain Barrier, Astrocytes, Sars Virus, Pericytes, Transcytosis, Covid-19, Sars-Cov-2
Cited by
- RhCMV reactivation in SARS-CoV-2 infected aged rhesus macaques. Front Immunol, 2025
- A data-mining analysis of host solute carrier family proteins in SARS-CoV-2 infection with reference to brain endothelial cells and the blood-brain barrier in COVID-19. Front Neurol, 2025
- Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants. Viruses, 2025